University of Alberta-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. Infectious Complications in Biologic and Targeted Therapies

    Springer International Publishing, pp. 1-473

  2. Preface

    Infectious Complications in Biologic and Targeted Therapies

2019

  1. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing

    PLoS ONE, Vol. 14, Núm. 7

2018

  1. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

    Clinical Microbiology and Infection, Vol. 24, pp. S95-S107

  2. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 32, Núm. 1, pp. 36-57

2017

  1. Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance

    Journal of Clinical Virology, Vol. 90, pp. 57-63

2016

  1. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 30, Núm. 3, pp. 119-143